Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)

China flag China · Delayed Price · Currency is CNY
7.29
+0.11 (1.53%)
Feb 27, 2026, 3:04 PM CST
Market Cap4.21B +64.2%
Revenue (ttm)816.95M +7.0%
Net Income95.72M +162.9%
EPS0.17 +183.3%
Shares Out577.21M
PE Ratio42.88
Forward PEn/a
Dividend0.29 (4.01%)
Ex-Dividend DateSep 11, 2025
Volume7,355,320
Average Volume9,685,042
Open7.24
Previous Close7.18
Day's Range7.18 - 7.29
52-Week Range3.60 - 7.78
Beta0.27
RSI49.50
Earnings DateApr 24, 2026

About SHE:002107

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, includ... [Read more]

Sector Healthcare
Founded 2003
Employees 1,018
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002107
Full Company Profile

Financial Performance

In 2025, SHE:002107's revenue was 816.95 million, an increase of 6.96% compared to the previous year's 763.79 million. Earnings were 95.72 million, an increase of 162.93%.

Financial Statements